-
About worms, NAMs and DART studies at WC12
Some thoughts of Nagi’s CSO Laurent Mouchiroud on NAMs in DART studies. Speaker at WC12 Niagara Falls.
-
A new approach to replace animal testing
Our CEO and co-founder, Matteo Cornaglia, speaks today about the future of New Approach Methodologies and how Nagi Bioscience is fulfilling this market need in an interview for Verve Ventures.
-
Santé ! Longévité !
Radio Télévision Suisse consulted our co-founder and CSO Laurent Mouchiroud about today’s advances in the field of aging and longevity research for the monthly health reportage.